These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2905830)

  • 1. [Prognostic significance of the T4 lymphocyte count in patients infected with CDC Class II and III HIV].
    Rüttimann S; Lavanchy JD; Meyer JL; Steinmann E
    Schweiz Med Wochenschr; 1988 Dec; 118(49):1844-6. PubMed ID: 2905830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.
    Fernandez-Cruz E; Fernandez AM; Gutierrez C; Garcia-Montes M; de la Morena MT; Rodriguez-Villanueva J; Longo N; Zabay JM
    Clin Exp Immunol; 1988 May; 72(2):190-5. PubMed ID: 3261660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna.
    Armbruster C; Kriwanek S; Vorbach H
    Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count.
    Rockstroh JK; Woitas RP; Brackmann HH; Kupfer B; Kaiser R; Schneweis KE; Sudhop T; Spengler U
    Eur J Med Res; 1998 May; 3(5):223-30. PubMed ID: 9580568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors.
    Luder E; Godfrey E; Godbold J; Simpson DM
    J Am Diet Assoc; 1995 Jun; 95(6):655-60. PubMed ID: 7759740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
    Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
    Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
    Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA
    AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Replication indexes of the human immunodeficiency virus: predictive value of viral culture and blood antigens].
    Carton JA; Melón S; Maradona JA; de Oña M; Asensi V; Martínez A; Cárcaba V
    Med Clin (Barc); 1994 May; 102(19):725-30. PubMed ID: 8041201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
    Nightingale SD; Jockusch JD; Haslund I; Cal SX; Peterson DM; Loss SD
    Arch Intern Med; 1993 Jun; 153(11):1313-8. PubMed ID: 8099477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
    Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
    J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum beta 2-microglobulin and human immunodeficiency virus infection.
    Lacey JN; Forbes MA; Waugh MA; Cooper EH; Hambling MH
    AIDS; 1987 Jul; 1(2):123-7. PubMed ID: 3130078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantification of viremia in patients infected with human immunodeficiency virus with different degrees of immunosuppression].
    Soriano V; Gómez-Cano M; Mas A; Villalba N; Castilla J; Adrados M; Laguna F; Polo R; González-Lahoz J
    Rev Clin Esp; 1997 Dec; 197(12):810-3. PubMed ID: 9477671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
    An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of the assay of serum anti-p25 antibodies in patients with human immunodeficiency virus (HIV-1) infection].
    Fenouillet E; Blanes N; Coutellier A; Demarquest J; Rozenbaum W; Gluckman JC
    Ann Med Interne (Paris); 1993; 144(5):329-34. PubMed ID: 8291842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma selenium concentration and glutathione peroxidase activity in HIV-1/AIDS infected patients: a correlation with the disease progression.
    Ogunro PS; Ogungbamigbe TO; Elemie PO; Egbewale BE; Adewole TA
    Niger Postgrad Med J; 2006 Mar; 13(1):1-5. PubMed ID: 16633369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexually transmitted diseases in 1161 HIV-positive patients: a 38-month prospective study in southern Spain.
    Muñoz-Pérez MA; Rodriguez-Pichardo A; Camacho Martinez F
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):221-6. PubMed ID: 9883433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group.
    Hanson DL; Chu SY; Farizo KM; Ward JW
    Arch Intern Med; 1995 Jul; 155(14):1537-42. PubMed ID: 7605156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
    Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
    East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.